Genome-Wide miRNA Expression Profiling of Molecular Subgroups of Peripheral T-cell Lymphoma

Purpose: Peripheral T-cell lymphoma (PTCL) is a heterogeneous group of non–Hodgkin lymphomas with aggressive clinical behavior. We performed comprehensive miRNA profiling in PTCLs and corresponding normal CD4+ Th1/2 and TFH-like polarized subsets to elucidate the role of miRNAs in T-cell lymphomagenesis. Experimental Design: We used nCounter (NanoString Inc) for miRNA profiling and validated using Taqman qRT-PCR (Applied Biosystems, Inc). Normal CD4+ T cells were polarized into effector Th subsets using signature cytokines, and miRNA significance was revealed using functional experiments. Results: Effector Th subsets showed distinct miRNA expression with corresponding transcription factor expression (e.g., BCL6/miR-19b, -106, -30d, -26b, in IL21-polarized; GATA3/miR-155, miR-337 in Th2-polarized; and TBX21/miR-181a, -331-3p in Th1-polarized cells). Integration of miRNA signatures suggested activation of TCR and PI3K signaling in IL21-polarized cells, ERK signaling in Th1-polarized cells, and AKT–mTOR signaling in Th2-polarized cells, validated at protein level. In neoplastic counterparts, distinctive miRNAs were identified and confirmed in an independent cohort. Integrative miRNA–mRNA analysis identified a decrease in target transcript abundance leading to deregulation of sphingolipid and Wnt signaling and epigenetic dysregulation in angioimmunoblastic T-cell lymphoma (AITL), while ERK, MAPK, and cell cycle were identified in PTCL subsets, and decreased target transcript abundance was validated in an independent cohort. Elevated expression of miRNAs (miR-126-3p, miR-145-5p) in AITL was associated with poor clinical outcome. In silico and experimental validation suggest two targets (miR-126→ SIPR2 and miR-145 → ROCK1) resulting in reduced RhoA-GTPase activity and T–B-cell interaction. Conclusions: Unique miRNAs and deregulated oncogenic pathways are associated with PTCL subtypes. Upregulated miRNA-126-3p and miR-145-5p expression regulate RhoA-GTPase and inhibit T-cell migration, crucial for AITL pathobiology.

[1]  Jessica K. Gagnon,et al.  ERK signalling: a master regulator of cell behaviour, life and fate , 2020, Nature Reviews Molecular Cell Biology.

[2]  G. Meister,et al.  miR-181a Modulation of ERK-MAPK Signaling Sustains DC-SIGN Expression and Limits Activation of Monocyte-Derived Dendritic Cells. , 2020, Cell reports.

[3]  Christina Backes,et al.  miEAA 2.0: integrating multi-species microRNA enrichment analysis and workflow management systems , 2020, bioRxiv.

[4]  L. Staudt,et al.  Reproducing the Molecular Subclassification of Peripheral T-cell Lymphoma-NOS by Immunohistochemistry. , 2019, Blood.

[5]  L. Staudt,et al.  Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma. , 2019, Blood.

[6]  K. Stamatakis,et al.  The Dual-Specificity Phosphatase 10 (DUSP10): Its Role in Cancer, Inflammation, and Immunity , 2019, International journal of molecular sciences.

[7]  Dirk Baumjohann,et al.  MicroRNA‐mediated regulation of T follicular helper and T follicular regulatory cell identity , 2019, Immunological reviews.

[8]  K. Oestreich,et al.  In Vitro Differentiation of Effector CD4+ T Helper Cell Subsets. , 2019, Methods in molecular biology.

[9]  M. Guo,et al.  MicroRNA-126 Deficiency Affects the Development of Thymus CD4+ Single-Positive Cells through Elevating IRS-1 , 2018, International Archives of Allergy and Immunology.

[10]  J. Iqbal,et al.  Molecular Insights Into Pathogenesis of Peripheral T Cell Lymphoma: a Review , 2018, Current Hematologic Malignancy Reports.

[11]  A. Ridley,et al.  Rho GTPase signaling complexes in cell migration and invasion , 2018, The Journal of cell biology.

[12]  J. Zhao,et al.  MicroRNA‐126 deficiency enhanced the activation and function of CD4+T cells by elevating IRS‐1 pathway , 2018, Clinical and experimental immunology.

[13]  Ken Cheng,et al.  Roles of Rap1 signaling in tumor cell migration and invasion , 2017, Cancer biology & medicine.

[14]  Chen Wang,et al.  MicroRNA profiling in peripheral T-cell lymphoma, not otherwise specified. , 2017, Cancer biomarkers : section A of Disease markers.

[15]  C. Cogoni,et al.  MicroRNA in Control of Gene Expression: An Overview of Nuclear Functions , 2016, International journal of molecular sciences.

[16]  Motoki Osawa,et al.  MicroRNA Stability in FFPE Tissue Samples: Dependence on GC Content , 2016, PloS one.

[17]  Ryan D. Morin,et al.  Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas. , 2016, Blood.

[18]  L. Staudt,et al.  Recurrent activating mutations of CD28 in peripheral T-cell lymphomas , 2016, Leukemia.

[19]  W. Chan,et al.  Genomic signatures in T-cell lymphoma: How can these improve precision in diagnosis and inform prognosis? , 2016, Blood reviews.

[20]  Sanghyuk Lee,et al.  A highly recurrent novel missense mutation in CD28 among angioimmunoblastic T-cell lymphoma patients , 2015, Haematologica.

[21]  B. Zhao,et al.  Sphingosine 1-phosphate Receptor 2 Signaling Suppresses Macrophage Phagocytosis and Impairs Host Defense against Sepsis , 2015, Anesthesiology.

[22]  O. Merkel,et al.  MicroRNA and ALK-positive anaplastic large cell lymphoma. , 2015, Frontiers in bioscience.

[23]  N. Gebauer,et al.  Dysregulation of microRNAs in angioimmunoblastic T-cell lymphoma. , 2015, Anticancer research.

[24]  R. Casellas,et al.  MicroRNA-146a regulates ICOS–ICOSL signalling to limit accumulation of T follicular helper cells and germinal centres , 2015, Nature Communications.

[25]  M. Rosenfeld,et al.  The transcription factor KLF2 restrains CD4+ T follicular helper cell differentiation , 2015, Immunity.

[26]  L. Staudt,et al.  Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma. , 2015, Blood.

[27]  Andreas Radbruch,et al.  ICOS maintains the T follicular helper cell phenotype by down-regulating Krüppel-like factor 2 , 2015, The Journal of experimental medicine.

[28]  L. Staudt,et al.  IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma. , 2014, Blood.

[29]  S. Pileri,et al.  Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified , 2014, Blood Cancer Journal.

[30]  Margaret Alexander,et al.  miR-155 promotes T follicular helper cell accumulation during chronic, low-grade inflammation. , 2014, Immunity.

[31]  M. Kubo,et al.  Sphingosine-1-phosphate receptor 2 is critical for follicular helper T cell retention in germinal centers , 2014, The Journal of experimental medicine.

[32]  M. Piris,et al.  The RHOA G17V gene mutation occurs frequently in peripheral T-cell lymphoma and is associated with a characteristic molecular signature. , 2014, Blood.

[33]  M. Kaminski,et al.  The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomas , 2014, Blood Cancer Journal.

[34]  Q. Cheng,et al.  ROCK1, a novel target of miR-145, promotes glioma cell invasion. , 2014, Molecular medicine reports.

[35]  I. Lossos,et al.  Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas , 2014, Nature Genetics.

[36]  W. Chan,et al.  STAT3-mediated activation of microRNA cluster 17~92 promotes proliferation and survival of ALK-positive anaplastic large cell lymphoma , 2014, Haematologica.

[37]  L. Staudt,et al.  Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. , 2012, Blood.

[38]  W. Chan,et al.  MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma. , 2013, Blood.

[39]  K. Mark Ansel,et al.  MicroRNA-mediated regulation of T helper cell differentiation and plasticity , 2013, Nature Reviews Immunology.

[40]  J. Cannons,et al.  T follicular helper cell diversity and plasticity. , 2013, Trends in immunology.

[41]  N. Komatsu,et al.  Computational dissection of distinct microRNA activity signatures associated with peripheral T cell lymphoma subtypes , 2013, Leukemia.

[42]  W. Leonard,et al.  Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. , 2013, Immunity.

[43]  Y. Li,et al.  MicroRNA-126 regulates the induction and function of CD4+ Foxp3+ regulatory T cells through PI3K/AKT pathway , 2013, Journal of cellular and molecular medicine.

[44]  J. Pouysségur,et al.  Polar Opposites: Erk Direction of CD4 T Cell Subsets , 2012, The Journal of Immunology.

[45]  L. Staudt,et al.  Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis. , 2012, Blood.

[46]  W. Chan,et al.  IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma. , 2012, Blood.

[47]  Hua Huang,et al.  ERK1 is important for Th2 differentiation and development of experimental asthma , 2012, The FASEB Journal.

[48]  J. O’Shea,et al.  Early Th1 cell differentiation is marked by a Tfh cell-like transition. , 2011, Immunity.

[49]  F. Marabita,et al.  Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+ T cells by the microRNA miR-125b , 2011, Nature Immunology.

[50]  J. Cavaille,et al.  Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas , 2011, Leukemia.

[51]  Q. Lu,et al.  MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. , 2011, Arthritis and rheumatism.

[52]  R. Søkilde,et al.  Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL). , 2011, Blood.

[53]  D. Staus,et al.  Sphingosine 1-Phosphate Receptor 2 Signals Through Leukemia-Associated RhoGEF (LARG), to Promote Smooth Muscle Cell Differentiation , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[54]  R. Greil,et al.  Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK− anaplastic large-cell lymphoma , 2010, Proceedings of the National Academy of Sciences.

[55]  W. Chan,et al.  Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. , 2010, Blood.

[56]  Jun Yu,et al.  A Brief Review on the Mechanisms of miRNA Regulation , 2009, Genom. Proteom. Bioinform..

[57]  C. Egwuagu STAT3 in CD4+ T helper cell differentiation and inflammatory diseases. , 2009, Cytokine.

[58]  B. Kroesen,et al.  miRNA profiling of B-cell subsets: specific miRNA profile for germinal center B cells with variation between centroblasts and centrocytes , 2009, Laboratory Investigation.

[59]  Dereje D. Jima,et al.  Patterns of microRNA expression characterize stages of human B-cell differentiation. , 2009, Blood.

[60]  F. Macian,et al.  IL-2 signaling prevents T cell anergy by inhibiting the expression of anergy-inducing genes. , 2009, Molecular immunology.

[61]  Robert Tibshirani,et al.  Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. , 2008, Blood.

[62]  D. Weisenburger,et al.  International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[63]  S. Pileri,et al.  Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation. , 2007, Cancer research.

[64]  Christian Gisselbrecht,et al.  The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. , 2007, Blood.

[65]  Thomas Ragg,et al.  The RIN: an RNA integrity number for assigning integrity values to RNA measurements , 2006, BMC Molecular Biology.

[66]  W. Pear,et al.  Notch signaling is an important regulator of type 2 immunity , 2005, The Journal of experimental medicine.

[67]  J. Pouysségur,et al.  The role of erk1 and erk2 in multiple stages of T cell development. , 2005, Immunity.

[68]  Justine R. Smith,et al.  Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma. , 2003, Blood.

[69]  S. Jewell,et al.  Copyright © American Society for Investigative Pathology Review Effect of Fixatives and Tissue Processing on the Content and Integrity of Nucleic Acids , 2022 .

[70]  M. Rincón,et al.  The two faces of IL-6 on Th1/Th2 differentiation. , 2002, Molecular immunology.

[71]  Yi Zheng,et al.  RhoA inactivation inhibits cell migration but does not mediate the effects of polyamine depletion. , 2002, Gastroenterology.

[72]  B. Nathwani,et al.  Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[73]  Federica Sallusto,et al.  Follicular B Helper T Cells Express Cxc Chemokine Receptor 5, Localize to B Cell Follicles, and Support Immunoglobulin Production , 2000, The Journal of experimental medicine.

[74]  P. Loetscher,et al.  Cxc Chemokine Receptor 5 Expression Defines Follicular Homing T Cells with B Cell Helper Function , 2000, The Journal of experimental medicine.

[75]  R. Perlmutter,et al.  T cell antigen receptor-mediated activation of the Ras/mitogen-activated protein kinase pathway controls interleukin 4 receptor function and type-2 helper T cell differentiation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[76]  W. Ouyang,et al.  Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. , 1998, Immunity.